Cervical Carcinosarcoma, also known as cervical malignant mixed mesodermal mullerian tumor, is related to carcinosarcoma and cervical adenosarcoma. An important gene associated with Cervical Carcinosarcoma is TTF1 (Transcription Termination Factor 1), and among its related pathways/superpathways is Hematopoietic Stem Cells and Lineage-specific Markers. The drugs Paclitaxel and Bevacizumab have been mentioned in the context of this disorder. Affiliated tissues include endothelial and cervix, and related phenotype is Increased NF-kappaB reporter expression.